Drug and Alcohol Dependence
Volume 65, Issue 3 , Pages 303-308 , 1 February 2002

Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic–androgenic steroid injectors in Victoria, Australia

  • Campbell Aitken

      Affiliations

    • The Macfarlane Burnet Centre for Medical Research, P.O. Box 254, Fairfield, Victoria 3078, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-3-9282-2114; fax: +61-3-9482-3123
  • ,
  • Cheryl Delalande

      Affiliations

    • North Eastern AIDS Prevention Program, Darebin and Banyule Community Health Services, Victoria, Australia
  • ,
  • Kay Stanton

      Affiliations

    • North Eastern AIDS Prevention Program, Darebin and Banyule Community Health Services, Victoria, Australia

Received 23 February 2001 ,Revised 6 June 2001 ,Accepted 6 June 2001.

References 

  1. Bolding G, Sherr L, Maguire M, Elford J. HIV risk behaviours among gay men who use anabolic steroids. Addiction. 1999;94(12):1829–1835
  2. Bryden AA, Rothwell PJ, O'Reilly PH. Anabolic steroid abuse and renal-cell carcinoma. Lancet. 1995;346(8985):1306–1307
  3. Crampin AC, Lamagni TL, Hope VD, Newham JA, Lewis KM, Parry JV, et al. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Epidemiol. Infect. 1998;121(2):381–386
  4. Creagh TM, Rubin A, Evans DJ. Hepatic tumours induced by anabolic steroids in an athlete. J. Clin. Pathol. 1988;41:441–443
  5. Crofts N, Aitken CK. Incidence of and risk behaviours for blood-borne viruses in a cohort of injecting drug users in Victoria, 1990–1995. Med. J. Aust. 1997;167:17–20
  6. Crofts N, Jolley D, Kaldor J, van Beek I. The epidemiology of Hepatitis C virus infection among injecting drug users in Australia. J. Epidemiol. Commun. Health. 1997;516:692–697
  7. Delalande C, Aitken CK, Mercuri P, Stanton K. Risky practices among people who inject steroids. Med. J. Aust. 1998;169(1):62
  8. Fussell, S.W., 1991. Muscle: confessions of an unlikely bodybuilder, Sphere Books Ltd, London.
  9. Gaede JT, Montine TJ. Massive pulmonary embolus and anabolic steroid abuse. J. Am. Med. Assoc. 1992;267(17):2328–2329
  10. Huie MJ. An acute myocardial infarction occurring in an anabolic steroid user. Med. Sci. Sports Exerc. 1994;26(4):408–413
  11. Lenaway DD, Guilfoile A, Rebchook G. Multiple HIV-risk behaviors among injection-steroid users. AIDS Public Policy J. 1992;7(3):184–186
  12. Loxley W, Phillips M, Carruthers S, Bevan J. The Australian Study of HIV and Injecting Drug Use. Part I: Prevalence for HIV hepatitis B and hepatitis C among injecting drug users in four Australian cities. Drug Alcohol Depend. 1997;16:207–221
  13. Morrison CL. Anabolic steroid users identified by needle and syringe exchange contact. Drug Alcohol Depend. 1994;36:153–156
  14. Nemechek PM. Anabolic steroid users—another potential risk group for HIV infection. New Engl. J. Med. 1991;325(5):357
  15. National Centre in HIV Epidemiology and Clinical Research, 2000. HIV/AIDS, Hepatitis C and Sexually Transmissible Infections in Australia: annual surveillance report, 2000, National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney.
  16. O'Sullivan AJ, Kennedy MC, Casey JH, Day RO, Corrigan B, Wodak AD. Anabolic–androgenic steroids: medical assessment of present, past and potential users. Med. J. Aust. 2000;173:323–327
  17. Perry HM, Wright D, Littlepage BN. Dying to be big: a review of anabolic steroid use. Br. J. Sports Med. 1992;26(4):259–261
  18. Rich JD, Dickinson BP, Carney JM, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS. 1998;12(17):2345–2350
  19. Rich JD, Dickinson BP, Merriman NA, Flanigan TP. Hepatitis C virus infection related to anabolic–androgenic steroid injection in a recreational weight lifter. Am. J. Gastroenterol. 1998;93(9):1598
  20. Rich JD, Foisie CK, Towe CW, Dickinson BP, McKenzie M, Salas CM. Needle exchange program participation by anabolic steroid injectors, United States 1998. Drug Alcohol Depend. 1999;56(2):157–160
  21. Scott MJ, Scott MJ. HIV infection associated with injections of anabolic steroids. J. Am. Med. Assoc. 1989;262:207–208
  22. Sklarek HM, Mantovani RP, Erens E, Heisler D, Niederman MS, Fein AM. AIDS in a bodybuilder using anabolic steroids. New Engl. J. Med. 1984;311:1701
  23. van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor J. Infection with HIV and hepatitis C among injecting drug users in a prevention setting: retrospective cohort study. Br. Med. J. 1998;317:433–437

PII: S0376-8716(01)00174-0

doi: 10.1016/S0376-8716(01)00174-0

Drug and Alcohol Dependence
Volume 65, Issue 3 , Pages 303-308 , 1 February 2002